German Cancer Research Center-DKFZ, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. National Center for Radiation Research in Oncology - NCRO, Heidelberg Institute for Radiation Oncology - HIRO Heidelberg, Germany. Author to whom any correspondence should be addressed.
Phys Med Biol. 2019 Jan 4;64(1):015015. doi: 10.1088/1361-6560/aaf400.
Inverse treatment planning in intensity modulated particle therapy (IMPT) with scanned carbon-ion beams is currently based on the optimization of RBE-weighted dose to satisfy requirements of target coverage and limited toxicity to organs-at-risk (OARs) and healthy tissues. There are many feasible IMPT plans that meet these requirements, which allows the introduction of further criteria to narrow the selection of a biologically optimal treatment plan. We propose a novel treatment planning strategy based on the simultaneous optimization of RBE-weighted dose and nanometric ionization details (ID) as a new physical characteristic of the delivered plan beyond LET. In particular, we focus on the distribution of large ionization clusters (more than 3 ionizations) to enhance the biological effect across the target volume while minimizing biological effect in normal tissues. Carbon-ion treatment plans for different patient geometries and beam configurations generated with the simultaneous optimization strategy were compared against reference plans obtained with RBE-weighted dose optimization alone. Quality indicators, inhomogeneity index and planning volume histograms of RBE-weighted dose and large ionization clusters were used to evaluate the treatment plans. We show that with simultaneous optimization, ID distributions can be optimized in carbon-ion radiotherapy without compromising the RBE-weighted dose distributions. This strategy can potentially be used to account for optimization of endpoints closely related to radiation quality to achieve better tumor control and reduce risks of complications.
反演调强碳离子束治疗计划(IMPT)目前基于 RBE 加权剂量的优化,以满足靶区覆盖和对危及器官(OARs)和健康组织的毒性限制的要求。有许多可行的 IMPT 计划满足这些要求,这允许引入进一步的标准来缩小生物学最优治疗计划的选择范围。我们提出了一种基于 RBE 加权剂量和纳米级电离细节(ID)的同时优化的新治疗计划策略,作为超越 LET 的传递计划的新物理特性。特别是,我们关注大电离簇(超过 3 次电离)的分布,以增强目标体积内的生物学效应,同时使正常组织中的生物学效应最小化。用同时优化策略生成的不同患者几何形状和束配置的碳离子治疗计划与仅用 RBE 加权剂量优化获得的参考计划进行了比较。使用不均匀性指数和 RBE 加权剂量和大电离簇的计划体积直方图等质量指标来评估治疗计划。我们表明,通过同时优化,可以在碳离子放射治疗中优化 ID 分布,而不会影响 RBE 加权剂量分布。该策略可用于优化与辐射质量密切相关的终点,以实现更好的肿瘤控制并降低并发症风险。